Therefore, this study aims to explore the value of machine learning-based ultrasomics for non-invasive prediction of CK19 expression in HCC patients, and to further evaluate the generalization ability of the prediction model using an independent external validation dataset. The gene discussed is KRT19; the disease is hepatocellular carcinoma.